Hemophagocytic lymphohistiocytosis natural history, complications and prognosis

Jump to navigation Jump to search

Hemophagocytic lymphohistiocytosis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophagocytic lymphohistiocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophagocytic lymphohistiocytosis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophagocytic lymphohistiocytosis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophagocytic lymphohistiocytosis natural history, complications and prognosis

CDC on Hemophagocytic lymphohistiocytosis natural history, complications and prognosis

Hemophagocytic lymphohistiocytosis natural history, complications and prognosis in the news

Blogs on Hemophagocytic lymphohistiocytosis natural history, complications and prognosis

Directions to Hospitals Treating Hemophagocytic lymphohistiocytosis

Risk calculators and risk factors for Hemophagocytic lymphohistiocytosis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Natural History

Complications

Prognosis

  • Secondary HLH in some individuals may be self-limited because patients are able to fully recover after having received only supportive medical treatment. However, long-term remission without the use of cytotoxic and immune-suppressive therapies is unlikely in the majority of adults with HLH and in those with CNS involvement.
  • Without treatment, most people with familial hemophagocytic lymphohistiocytosis survive only a few months.

References

Template:WS Template:WH